Novel Small-Molecule Inhibitors of BCL-Xl to Treat Lung Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-12-2272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2013English

Imaging Cellular Distribution of BCL Inhibitors Using Small Molecule Drug Conjugates

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2014English

Investigation of TRPM4 in Prostate Cancer Cells With Novel Small Molecule Inhibitors

Biophysical Journal
Biophysics
2019English

Design, Synthesis, and Computational Studies of Inhibitors of BCL-Xl

English

Genistein Promotes Ionizing Radiation-Induced Cell Death by Reducing Cytoplasmic BCL-xL Levels in Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2018English

Design, Synthesis, and Computational Studies of Inhibitors of BCL-Xl

English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Tackling ALK in Non-Small Cell Lung Cancer: The Role of Novel Inhibitors

Translational Lung Cancer Research
Oncology
2016English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy